Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma.

[1]  E. Kostenis,et al.  The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking1 , 2007, The Journal of Immunology.

[2]  T. Yoshino,et al.  Role of prostaglandin D2 and E2 terminal synthases in chronic rhinosinusitis , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  C. Bachert,et al.  Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. , 2005, The Journal of allergy and clinical immunology.

[4]  L. Borish,et al.  Molecular and Cellular Staging for the Severity of Chronic Rhinosinusitis , 2004, The Laryngoscope.

[5]  B. Vargaftig,et al.  Prostaglandin E2 and dexamethasone regulate eosinophil differentiation and survival through a nitric oxide- and CD95-dependent pathway. , 2004, Nitric oxide : biology and chemistry.

[6]  F. Cipollone,et al.  Balance Between PGD Synthase and PGE Synthase Is a Major Determinant of Atherosclerotic Plaque Instability in Humans , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Y. Urade,et al.  Effects of Interleukin-1β and Prostaglandin E2 on Prostaglandin D Synthase Production in Cultivated Rat Leptomeningeal Cells , 2004, Journal of Cerebral Blood Flow and Metabolism.

[8]  M. Sanak,et al.  Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. , 2003, The Journal of allergy and clinical immunology.

[9]  L. Borish.  The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  Yoshihiro Urade,et al.  Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1 , 2002, The Journal of Immunology.

[11]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[12]  A. Leff.  Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways , 2000, American journal of respiratory and critical care medicine.

[13]  L. Ertama,et al.  Nasal polyposis: clinical course during 20 years. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  B. Vargaftig,et al.  Murine myeloid progenitor responses to GM‐CSF and eosinophil precursor responses to IL‐5 represent distinct targets for downmodulation by prostaglandin E2 , 2000, British journal of pharmacology.

[15]  M. Kowalski,et al.  Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. , 2000, American journal of respiratory and critical care medicine.

[16]  D. Stevenson,et al.  Aspirin-induced asthma: advances in pathogenesis and management. , 1999, The Journal of allergy and clinical immunology.

[17]  J. Mullol,et al.  Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. , 1999, American journal of respiratory and critical care medicine.

[18]  R. Slavin.  Complications of allergic rhinitis: implications for sinusitis and asthma. , 1998, The Journal of allergy and clinical immunology.

[19]  R. Naclerio,et al.  Sinusitis: bench to bedside. Current findings, future directions. , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[20]  Q. Hamid,et al.  Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. , 1996, American journal of respiratory cell and molecular biology.

[21]  W. Hosemann,et al.  Eicosanoids from biopsy of normal and polypous nasal mucosa. , 1996, Rhinology.

[22]  I. Pavord,et al.  Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.

[23]  W. Busse,et al.  Asthma and Rhinitis , 1995 .

[24]  J. Morrow,et al.  Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. , 1994, The Journal of allergy and clinical immunology.

[25]  R. L. Roper,et al.  A new view of prostaglandin E regulation of the immune response. , 1991, Immunology today.

[26]  R. A. Coleman,et al.  Prostanoid‐induced contraction of human bronchial smooth muscle is mediated by TP‐receptors , 1989, British journal of pharmacology.

[27]  J. Murray,et al.  Release of prostaglandin D2 into human airways during acute antigen challenge. , 1986, The New England journal of medicine.

[28]  D. Stevenson,et al.  Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. , 1984, The Journal of allergy and clinical immunology.

[29]  S. Holgate,et al.  The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. , 1984, The New England journal of medicine.

[30]  M. Samter,et al.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. , 1968, Annals of internal medicine.

[31]  J. Christman,et al.  An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids. , 2008, Analytical biochemistry.

[32]  W. Henderson,et al.  Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. , 2003, The Journal of allergy and clinical immunology.

[33]  松岡 俊行.  Prostaglandin D2 as a mediator of allergic asthmaに関する研究 , 2000 .

[34]  K. Gomi,et al.  Dependent Mechanism 3 / EP 1 Through an EP Colony-Stimulating Factor by Mast Cells Granulocyte-Macrophage IgE-Mediated Production of IL-6 and Selectively Enhances the 2 Prostaglandin E , 2000 .

[35]  H. Stammberger.  Surgical treatment of nasal polyps: past, present, and future. , 1999, Allergy.

[36]  I. Tillie‐Leblond,et al.  Sequential evaluation of pulmonary function and bronchial hyperresponsiveness in patients with nasal polyposis: a prospective study. , 1997, American journal of respiratory and critical care medicine.

[37]  A. Sousa,et al.  Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. , 1996, American journal of respiratory and critical care medicine.

[38]  A. Drake-lee.  Medical treatment of nasal polyps. , 1994, Rhinology.

[39]  J. Morrow,et al.  Formation of PGD2 after allergen inhalation in atopic asthmatics. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[40]  S. Spector,et al.  Sinusitis and asthma. , 1990, The Journal of asthma : official journal of the Association for the Care of Asthma.